和黄医药
港股通 官网
( 00013.hk)
市盈率-71.74市净率4.12市销率5.00股息率0.00%上市时间2021-06-30股价27.30港币 (-2.15% , 8,151.15万港币) 市值237.94亿港币总股本8.72亿上市至今年化投资收益率-20.82%港股通持仓占H股比例21.99%累计做空占H股本比1.49%
所属三级行业药品 (恒生) 市盈率17.01市净率1.41市销率1.10股息率3.12%
所属指数指数纳入纳出
备注 (0): 双击编辑备注
发表讨论

和黄医药(00013) - 历史董事名单

# 姓名职衔职位委任日期辞任日期
1楊凌Non Executive Director2023-07-13--
2孫樂非Non Executive Director2022-05-162023-07-13
3MOK Shu Kam TonyIndependent Non Executive Director2017-10-01--
4JACK Graeme AllanIndependent Non Executive Director - A/F2017-03-01--
5蘇慰國Executive DirectorCEO2017-03-01--
6CARTER Rutherford PaulIndependent Non Executive Director2017-02-01--
7KAREN Jean FERRANTEIndependent Non Executive Director2017-02-012023-05-12
8ELDAR DanNon Executive Director2016-08-01--
9鄭澤鋒Executive Director2011-02-01--
10施熙德Non Executive Director2006-04-01--
11HOGG Christian LawrenceExecutive DirectorCEO2006-04-012022-03-03
12杜志強Executive DirectorChairman2000-12-01--